SS
FLGT icon

Steve Schonfeld’s Fulgent Genetics FLGT Stock Holding History

Steve Schonfeld’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Buy
+10,109
New +$171K ﹤0.01% 2183
2026
Q1 		– Sell
-30,503
Closed -$801K – 2368
2025
Q4 		$801K Buy
+30,503
New +$791K ﹤0.01% 1215
2024
Q3 		– Sell
-31,700
Closed -$622K – 2161
2024
Q2 		$622K Buy
31,700
+14,070
+80% +$294K ﹤0.01% 1396
2024
Q1 		$383K Buy
17,630
+9,030
+105% +$224K ﹤0.01% 1566
2023
Q4 		$249K Sell
8,600
-13,100
-60% -$351K ﹤0.01% 1483
2023
Q3 		$580K Buy
21,700
+7,730
+55% +$264K ﹤0.01% 1168
2023
Q2 		$517K Buy
+13,970
New +$487K ﹤0.01% 1211
2023
Q1 		– Sell
-13,923
Closed -$415K – 2261
2022
Q4 		$415K Sell
13,923
-1,630
-10% -$58.3K ﹤0.01% 1632
2022
Q3 		$593K Buy
15,553
+2,287
+17% +$115K 0.01% 1628
2022
Q2 		$724K Buy
+13,266
New +$729K 0.01% 1168
2022
Q1 		– Sell
-2,559
Closed -$257K – 2692
2021
Q4 		$257K Buy
+2,559
New +$225K ﹤0.01% 1576

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steve Schonfeld's FLGT Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Fulgent Genetics (FLGT) in Q2 2026: 10,109 shares worth $207K. The stake represents ﹤0.01% of the portfolio and ranks #2183 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in FLGT as recently as Q4 2025.

Steve Schonfeld first reported a position in FLGT in Q4 2021 and has held it in 11 quarters since. The position peaked at $801K in Q4 2025. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Steve Schonfeld held 10,109 shares of Fulgent Genetics worth $207K as of Q2 2026.
  • Fulgent Genetics was a new Steve Schonfeld position in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2183 holding.
  • Steve Schonfeld first reported a position in Fulgent Genetics in Q4 2021 and has held it in 11 quarters since.
  • Steve Schonfeld's Fulgent Genetics position peaked at $801K in Q4 2025.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.